• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global and China Chronic Kidney Disease Drugs Market Insights, Forecast to 2026

report cover
  • 4 September 2020
  • Pharmaceuticals
  • 129 Pages
  • Report Code: 24LS-21558
  • Formate :   
Download FREE Report Sample Download PDF File

Chronic Kidney Disease Drugs -MARKET ADVISORY SERVICES

Chronic Kidney Disease Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Kidney Disease Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Chronic Kidney Disease Drugs market is segmented into
ACE Inhibitors
Calcium Channel Blockers
Beta Blockers
Others

Segment by Application, the Chronic Kidney Disease Drugs market is segmented into
Hospitals
Specialty Clinics

Regional and Country-level Analysis
The Chronic Kidney Disease Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Chronic Kidney Disease Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Chronic Kidney Disease Drugs Market Share Analysis
Chronic Kidney Disease Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Chronic Kidney Disease Drugs business, the date to enter into the Chronic Kidney Disease Drugs market, Chronic Kidney Disease Drugs product introduction, recent developments, etc.
The major vendors covered:
Keryx Biopharmaceuticals, Inc
Kissei Pharmaceutical Co., Ltd
AbbVie
GlaxoSmithKline
Sanofi
F. Hoffmann-La Roche Ltd
Pfizer
AstraZeneca
Amgen
Teva Pharmaceutical Industries
1 Study Coverage
1.1 Chronic Kidney Disease Drugs Product Introduction
1.2 Market Segments
1.3 Key Chronic Kidney Disease Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Chronic Kidney Disease Drugs Market Size Growth Rate by Type
1.4.2 ACE Inhibitors
1.4.3 Calcium Channel Blockers
1.4.4 Beta Blockers
1.4.5 Others
1.5 Market by Application
1.5.1 Global Chronic Kidney Disease Drugs Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Specialty Clinics
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Chronic Kidney Disease Drugs Market Size, Estimates and Forecasts
2.1.1 Global Chronic Kidney Disease Drugs Revenue 2015-2026
2.1.2 Global Chronic Kidney Disease Drugs Sales 2015-2026
2.2 Global Chronic Kidney Disease Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Chronic Kidney Disease Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global Chronic Kidney Disease Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Chronic Kidney Disease Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Chronic Kidney Disease Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Chronic Kidney Disease Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global Chronic Kidney Disease Drugs Revenue Forecast by Region (2021-2026)

3 Global Chronic Kidney Disease Drugs Competitor Landscape by Players
3.1 Global Top Chronic Kidney Disease Drugs Sales by Manufacturers
3.1.1 Global Chronic Kidney Disease Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Chronic Kidney Disease Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global Chronic Kidney Disease Drugs Manufacturers by Revenue
3.2.1 Global Chronic Kidney Disease Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Chronic Kidney Disease Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Chronic Kidney Disease Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Chronic Kidney Disease Drugs Revenue in 2019
3.2.5 Global Chronic Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Chronic Kidney Disease Drugs Price by Manufacturers
3.4 Global Chronic Kidney Disease Drugs Manufacturing Base Distribution, Product Types
3.4.1 Chronic Kidney Disease Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Chronic Kidney Disease Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Chronic Kidney Disease Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Chronic Kidney Disease Drugs Market Size by Type (2015-2020)
4.1.1 Global Chronic Kidney Disease Drugs Sales by Type (2015-2020)
4.1.2 Global Chronic Kidney Disease Drugs Revenue by Type (2015-2020)
4.1.3 Chronic Kidney Disease Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Chronic Kidney Disease Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Chronic Kidney Disease Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Chronic Kidney Disease Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Chronic Kidney Disease Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Chronic Kidney Disease Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Chronic Kidney Disease Drugs Market Size by Application (2015-2020)
5.1.1 Global Chronic Kidney Disease Drugs Sales by Application (2015-2020)
5.1.2 Global Chronic Kidney Disease Drugs Revenue by Application (2015-2020)
5.1.3 Chronic Kidney Disease Drugs Price by Application (2015-2020)
5.2 Chronic Kidney Disease Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Chronic Kidney Disease Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Chronic Kidney Disease Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Chronic Kidney Disease Drugs Price Forecast by Application (2021-2026)

6 China by Players, Type and Application
6.1 China Chronic Kidney Disease Drugs Market Size YoY Growth 2015-2026
6.1.1 China Chronic Kidney Disease Drugs Sales YoY Growth 2015-2026
6.1.2 China Chronic Kidney Disease Drugs Revenue YoY Growth 2015-2026
6.1.3 China Chronic Kidney Disease Drugs Market Share in Global Market 2015-2026
6.2 China Chronic Kidney Disease Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Chronic Kidney Disease Drugs Players by Sales (2015-2020)
6.2.2 China Top Chronic Kidney Disease Drugs Players by Revenue (2015-2020)
6.3 China Chronic Kidney Disease Drugs Historic Market Review by Type (2015-2020)
6.3.1 China Chronic Kidney Disease Drugs Sales Market Share by Type (2015-2020)
6.3.2 China Chronic Kidney Disease Drugs Revenue Market Share by Type (2015-2020)
6.3.3 China Chronic Kidney Disease Drugs Price by Type (2015-2020)
6.4 China Chronic Kidney Disease Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Chronic Kidney Disease Drugs Sales Forecast by Type (2021-2026)
6.4.2 China Chronic Kidney Disease Drugs Revenue Forecast by Type (2021-2026)
6.4.3 China Chronic Kidney Disease Drugs Price Forecast by Type (2021-2026)
6.5 China Chronic Kidney Disease Drugs Historic Market Review by Application (2015-2020)
6.5.1 China Chronic Kidney Disease Drugs Sales Market Share by Application (2015-2020)
6.5.2 China Chronic Kidney Disease Drugs Revenue Market Share by Application (2015-2020)
6.5.3 China Chronic Kidney Disease Drugs Price by Application (2015-2020)
6.6 China Chronic Kidney Disease Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Chronic Kidney Disease Drugs Sales Forecast by Application (2021-2026)
6.6.2 China Chronic Kidney Disease Drugs Revenue Forecast by Application (2021-2026)
6.6.3 China Chronic Kidney Disease Drugs Price Forecast by Application (2021-2026)

7 North America
7.1 North America Chronic Kidney Disease Drugs Market Size YoY Growth 2015-2026
7.2 North America Chronic Kidney Disease Drugs Market Facts & Figures by Country
7.2.1 North America Chronic Kidney Disease Drugs Sales by Country (2015-2020)
7.2.2 North America Chronic Kidney Disease Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada

8 Europe
8.1 Europe Chronic Kidney Disease Drugs Market Size YoY Growth 2015-2026
8.2 Europe Chronic Kidney Disease Drugs Market Facts & Figures by Country
8.2.1 Europe Chronic Kidney Disease Drugs Sales by Country
8.2.2 Europe Chronic Kidney Disease Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia

9 Asia Pacific
9.1 Asia Pacific Chronic Kidney Disease Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific Chronic Kidney Disease Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific Chronic Kidney Disease Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific Chronic Kidney Disease Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam

10 Latin America
10.1 Latin America Chronic Kidney Disease Drugs Market Size YoY Growth 2015-2026
10.2 Latin America Chronic Kidney Disease Drugs Market Facts & Figures by Country
10.2.1 Latin America Chronic Kidney Disease Drugs Sales by Country
10.2.2 Latin America Chronic Kidney Disease Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Chronic Kidney Disease Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Chronic Kidney Disease Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Chronic Kidney Disease Drugs Sales by Country
11.2.2 Middle East and Africa Chronic Kidney Disease Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Keryx Biopharmaceuticals, Inc
12.1.1 Keryx Biopharmaceuticals, Inc Corporation Information
12.1.2 Keryx Biopharmaceuticals, Inc Description and Business Overview
12.1.3 Keryx Biopharmaceuticals, Inc Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Products Offered
12.1.5 Keryx Biopharmaceuticals, Inc Recent Development
12.2 Kissei Pharmaceutical Co., Ltd
12.2.1 Kissei Pharmaceutical Co., Ltd Corporation Information
12.2.2 Kissei Pharmaceutical Co., Ltd Description and Business Overview
12.2.3 Kissei Pharmaceutical Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Products Offered
12.2.5 Kissei Pharmaceutical Co., Ltd Recent Development
12.3 AbbVie
12.3.1 AbbVie Corporation Information
12.3.2 AbbVie Description and Business Overview
12.3.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
12.3.4 AbbVie Chronic Kidney Disease Drugs Products Offered
12.3.5 AbbVie Recent Development
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Corporation Information
12.4.2 GlaxoSmithKline Description and Business Overview
12.4.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.4.4 GlaxoSmithKline Chronic Kidney Disease Drugs Products Offered
12.4.5 GlaxoSmithKline Recent Development
12.5 Sanofi
12.5.1 Sanofi Corporation Information
12.5.2 Sanofi Description and Business Overview
12.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Sanofi Chronic Kidney Disease Drugs Products Offered
12.5.5 Sanofi Recent Development
12.6 F. Hoffmann-La Roche Ltd
12.6.1 F. Hoffmann-La Roche Ltd Corporation Information
12.6.2 F. Hoffmann-La Roche Ltd Description and Business Overview
12.6.3 F. Hoffmann-La Roche Ltd Sales, Revenue and Gross Margin (2015-2020)
12.6.4 F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Products Offered
12.6.5 F. Hoffmann-La Roche Ltd Recent Development
12.7 Pfizer
12.7.1 Pfizer Corporation Information
12.7.2 Pfizer Description and Business Overview
12.7.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Pfizer Chronic Kidney Disease Drugs Products Offered
12.7.5 Pfizer Recent Development
12.8 AstraZeneca
12.8.1 AstraZeneca Corporation Information
12.8.2 AstraZeneca Description and Business Overview
12.8.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
12.8.4 AstraZeneca Chronic Kidney Disease Drugs Products Offered
12.8.5 AstraZeneca Recent Development
12.9 Amgen
12.9.1 Amgen Corporation Information
12.9.2 Amgen Description and Business Overview
12.9.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Amgen Chronic Kidney Disease Drugs Products Offered
12.9.5 Amgen Recent Development
12.10 Teva Pharmaceutical Industries
12.10.1 Teva Pharmaceutical Industries Corporation Information
12.10.2 Teva Pharmaceutical Industries Description and Business Overview
12.10.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Products Offered
12.10.5 Teva Pharmaceutical Industries Recent Development
12.11 Keryx Biopharmaceuticals, Inc
12.11.1 Keryx Biopharmaceuticals, Inc Corporation Information
12.11.2 Keryx Biopharmaceuticals, Inc Description and Business Overview
12.11.3 Keryx Biopharmaceuticals, Inc Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Products Offered
12.11.5 Keryx Biopharmaceuticals, Inc Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Chronic Kidney Disease Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Chronic Kidney Disease Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables

Table 1. Chronic Kidney Disease Drugs Market Segments

Table 2. Ranking of Global Top Chronic Kidney Disease Drugs Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Chronic Kidney Disease Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)

Table 4. Major Manufacturers of ACE Inhibitors

Table 5. Major Manufacturers of Calcium Channel Blockers

Table 6. Major Manufacturers of Beta Blockers

Table 7. Major Manufacturers of Others

Table 8. Global Chronic Kidney Disease Drugs Market Size Growth Rate by Application 2020-2026 (K MT)

Table 9. Global Chronic Kidney Disease Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026

Table 10. Global Chronic Kidney Disease Drugs Sales by Regions 2015-2020 (K MT)

Table 11. Global Chronic Kidney Disease Drugs Sales Market Share by Regions (2015-2020)

Table 12. Global Chronic Kidney Disease Drugs Revenue by Regions 2015-2020 (US$ Million)

Table 13. Global Chronic Kidney Disease Drugs Sales Forecast by Region (2021-2026) (K MT)

Table 14. Global Chronic Kidney Disease Drugs Sales by Manufacturers (2015-2020) (K MT)

Table 15. Global Chronic Kidney Disease Drugs Sales Share by Manufacturers (2015-2020)

Table 16. Global Chronic Kidney Disease Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

Table 17. Global Chronic Kidney Disease Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Kidney Disease Drugs as of 2019)

Table 18. Chronic Kidney Disease Drugs Revenue by Manufacturers (2015-2020) (US$ Million)

Table 19. Chronic Kidney Disease Drugs Revenue Share by Manufacturers (2015-2020)

Table 20. Key Manufacturers Chronic Kidney Disease Drugs Price (2015-2020) (USD/MT)

Table 21. Chronic Kidney Disease Drugs Manufacturers Manufacturing Base Distribution and Headquarters

Table 22. Manufacturers Chronic Kidney Disease Drugs Product Type

Table 23. Date of International Manufacturers Enter into Chronic Kidney Disease Drugs Market

Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 25. Global Chronic Kidney Disease Drugs Sales by Type (2015-2020) (K MT)

Table 26. Global Chronic Kidney Disease Drugs Sales Share by Type (2015-2020)

Table 27. Global Chronic Kidney Disease Drugs Revenue by Type (2015-2020) (US$ Million)

Table 28. Global Chronic Kidney Disease Drugs Revenue Share by Type (2015-2020)

Table 29. Chronic Kidney Disease Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)

Table 30. Global Chronic Kidney Disease Drugs Sales Share by Type (2021-2026)

Table 31. Global Chronic Kidney Disease Drugs Sales by Application (2015-2020) (K MT)

Table 32. Global Chronic Kidney Disease Drugs Sales Share by Application (2015-2020)

Table 33. Global Chronic Kidney Disease Drugs Sales Share by Application (2021-2026)

Table 34. Global Chronic Kidney Disease Drugs Sales Market Share Forecast by Application (2021-2026)

Table 35. Global Chronic Kidney Disease Drugs Revenue by Application (2015-2020) (US$ Million)

Table 36. Global Chronic Kidney Disease Drugs Revenue Market Share Forecast by Application (2021-2026)

Table 37. China Chronic Kidney Disease Drugs Sales (K MT) of Key Companies (2015-2020)

Table 38. China Chronic Kidney Disease Drugs Sales Share by Company (2015-2020)

Table 39. China Chronic Kidney Disease Drugs Revenue (US$ Million) by Company (2015-2020)

Table 40. China Chronic Kidney Disease Drugs Sales (K MT) by Type (2015-2020)

Table 41. China Chronic Kidney Disease Drugs Sales Share by Type (2015-2020)

Table 42. China Chronic Kidney Disease Drugs Revenue (US$ Million) Market Share by Type (2015-2020)

Table 43. China Chronic Kidney Disease Drugs Price (K MT) by Type (2015-2020)

Table 44. China Chronic Kidney Disease Drugs Sales (K MT) by Type (2021-2026)

Table 45. China Chronic Kidney Disease Drugs Sales Share by Type (2021-2026)

Table 46. China Chronic Kidney Disease Drugs Revenue (US$ Million) Market Share by Type (2021-2026)

Table 47. China Chronic Kidney Disease Drugs Revenue Share by Type (2021-2026)

Table 48. China Chronic Kidney Disease Drugs Price (K MT) by Type (2021-2026)

Table 49. China Chronic Kidney Disease Drugs Sales (K MT) by Application (2015-2020)

Table 50. China Chronic Kidney Disease Drugs Sales Share by Application (2015-2020)

Table 51. China Chronic Kidney Disease Drugs Revenue (US$ Million) Market Share by Application (2015-2020)

Table 52. China Chronic Kidney Disease Drugs Sales (K MT) by Application (2021-2026)

Table 53. China Chronic Kidney Disease Drugs Sales Share by Application (2021-2026)

Table 54. China Chronic Kidney Disease Drugs Revenue (US$ Million) Market Share by Application (2021-2026)

Table 55. China Chronic Kidney Disease Drugs Revenue Share by Application (2021-2026)

Table 56. North America Chronic Kidney Disease Drugs Sales by Country (2015-2020) (K MT)

Table 57. North America Chronic Kidney Disease Drugs Sales Market Share by Country (2015-2020)

Table 58. North America Chronic Kidney Disease Drugs Revenue by Country (2015-2020) (US$ Million)

Table 59. North America Chronic Kidney Disease Drugs Revenue Market Share by Country (2015-2020)

Table 60. Europe Chronic Kidney Disease Drugs Sales by Country (2015-2020) (K MT)

Table 61. Europe Chronic Kidney Disease Drugs Sales Market Share by Country (2015-2020)

Table 62. Europe Chronic Kidney Disease Drugs Revenue by Country (2015-2020) (US$ Million)

Table 63. Europe Chronic Kidney Disease Drugs Revenue Market Share by Country (2015-2020)

Table 64. Asia Pacific Chronic Kidney Disease Drugs Sales by Region (2015-2020) (K MT)

Table 65. Asia Pacific Chronic Kidney Disease Drugs Sales Market Share by Region (2015-2020)

Table 66. Asia Pacific Chronic Kidney Disease Drugs Revenue by Region (2015-2020) (US$ Million)

Table 67. Asia Pacific Chronic Kidney Disease Drugs Revenue Market Share by Region (2015-2020)

Table 68. Latin America Chronic Kidney Disease Drugs Sales by Country (2015-2020) (K MT)

Table 69. Latin America Chronic Kidney Disease Drugs Sales Market Share by Country (2015-2020)

Table 70. Latin Americaa Chronic Kidney Disease Drugs Revenue by Country (2015-2020) (US$ Million)

Table 71. Latin America Chronic Kidney Disease Drugs Revenue Market Share by Country (2015-2020)

Table 72. Middle East and Africa Chronic Kidney Disease Drugs Sales by Country (2015-2020) (K MT)

Table 73. Middle East and Africa Chronic Kidney Disease Drugs Sales Market Share by Country (2015-2020)

Table 74. Middle East and Africa Chronic Kidney Disease Drugs Revenue by Country (2015-2020) (US$ Million)

Table 75. Middle East and Africa Chronic Kidney Disease Drugs Revenue Market Share by Country (2015-2020)

Table 76. Keryx Biopharmaceuticals, Inc Corporation Information

Table 77. Keryx Biopharmaceuticals, Inc Description and Business Overview

Table 78. Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 79. Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Product

Table 80. Keryx Biopharmaceuticals, Inc Recent Development

Table 81. Kissei Pharmaceutical Co., Ltd Corporation Information

Table 82. Kissei Pharmaceutical Co., Ltd Description and Business Overview

Table 83. Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 84. Kissei Pharmaceutical Co., Ltd Product

Table 85. Kissei Pharmaceutical Co., Ltd Recent Development

Table 86. AbbVie Corporation Information

Table 87. AbbVie Description and Business Overview

Table 88. AbbVie Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 89. AbbVie Product

Table 90. AbbVie Recent Development

Table 91. GlaxoSmithKline Corporation Information

Table 92. GlaxoSmithKline Description and Business Overview

Table 93. GlaxoSmithKline Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 94. GlaxoSmithKline Product

Table 95. GlaxoSmithKline Recent Development

Table 96. Sanofi Corporation Information

Table 97. Sanofi Description and Business Overview

Table 98. Sanofi Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 99. Sanofi Product

Table 100. Sanofi Recent Development

Table 101. F. Hoffmann-La Roche Ltd Corporation Information

Table 102. F. Hoffmann-La Roche Ltd Description and Business Overview

Table 103. F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 104. F. Hoffmann-La Roche Ltd Product

Table 105. F. Hoffmann-La Roche Ltd Recent Development

Table 106. Pfizer Corporation Information

Table 107. Pfizer Description and Business Overview

Table 108. Pfizer Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 109. Pfizer Product

Table 110. Pfizer Recent Development

Table 111. AstraZeneca Corporation Information

Table 112. AstraZeneca Description and Business Overview

Table 113. AstraZeneca Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 114. AstraZeneca Product

Table 115. AstraZeneca Recent Development

Table 116. Amgen Corporation Information

Table 117. Amgen Description and Business Overview

Table 118. Amgen Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 119. Amgen Product

Table 120. Amgen Recent Development

Table 121. Teva Pharmaceutical Industries Corporation Information

Table 122. Teva Pharmaceutical Industries Description and Business Overview

Table 123. Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 124. Teva Pharmaceutical Industries Product

Table 125. Teva Pharmaceutical Industries Recent Development

Table 126. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 127. Key Challenges

Table 128. Market Risks

Table 129. Main Points Interviewed from Key Chronic Kidney Disease Drugs Players

Table 130. Chronic Kidney Disease Drugs Customers List

Table 131. Chronic Kidney Disease Drugs Distributors List

Table 132. Research Programs/Design for This Report

Table 133. Key Data Information from Secondary Sources

Table 134. Key Data Information from Primary Sources

List of Figures

Figure 1. Chronic Kidney Disease Drugs Product Picture

Figure 2. Global Chronic Kidney Disease Drugs Sales Market Share by Type in 2020 & 2026

Figure 3. ACE Inhibitors Product Picture

Figure 4. Calcium Channel Blockers Product Picture

Figure 5. Beta Blockers Product Picture

Figure 6. Others Product Picture

Figure 7. Global Chronic Kidney Disease Drugs Sales Market Share by Application in 2020 & 2026

Figure 8. Hospitals

Figure 9. Specialty Clinics

Figure 10. Chronic Kidney Disease Drugs Report Years Considered

Figure 11. Global Chronic Kidney Disease Drugs Market Size 2015-2026 (US$ Million)

Figure 12. Global Chronic Kidney Disease Drugs Sales 2015-2026 (K MT)

Figure 13. Global Chronic Kidney Disease Drugs Market Size Market Share by Region: 2020 Versus 2026

Figure 14. Global Chronic Kidney Disease Drugs Sales Market Share by Region (2015-2020)

Figure 15. Global Chronic Kidney Disease Drugs Sales Market Share by Region in 2019

Figure 16. Global Chronic Kidney Disease Drugs Revenue Market Share by Region (2015-2020)

Figure 17. Global Chronic Kidney Disease Drugs Revenue Market Share by Region in 2019

Figure 18. Global Chronic Kidney Disease Drugs Sales Share by Manufacturer in 2019

Figure 19. The Top 10 and 5 Players Market Share by Chronic Kidney Disease Drugs Revenue in 2019

Figure 20. Chronic Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 21. Global Chronic Kidney Disease Drugs Sales Market Share by Type (2015-2020)

Figure 22. Global Chronic Kidney Disease Drugs Sales Market Share by Type in 2019

Figure 23. Global Chronic Kidney Disease Drugs Revenue Market Share by Type (2015-2020)

Figure 24. Global Chronic Kidney Disease Drugs Revenue Market Share by Type in 2019

Figure 25. Global Chronic Kidney Disease Drugs Market Share by Price Range (2015-2020)

Figure 26. Global Chronic Kidney Disease Drugs Sales Market Share by Application (2015-2020)

Figure 27. Global Chronic Kidney Disease Drugs Sales Market Share by Application in 2019

Figure 28. Global Chronic Kidney Disease Drugs Revenue Market Share by Application (2015-2020)

Figure 29. Global Chronic Kidney Disease Drugs Revenue Market Share by Application in 2019

Figure 30. China Chronic Kidney Disease Drugs Sales Growth Rate 2015-2026 (K MT)

Figure 31. China Chronic Kidney Disease Drugs Revenue Growth Rate 2015-2026 (US$ Million)

Figure 32. China Chronic Kidney Disease Drugs Market Share in Global Market 2015-2026

Figure 33. China 5 and 10 Largest Chronic Kidney Disease Drugs Players Market Share by Revenue in Chronic Kidney Disease Drugs in 2019

Figure 34. China Chronic Kidney Disease Drugs Revenue Share by Type (2015-2020)

Figure 35. China Chronic Kidney Disease Drugs Revenue Growth Rate by Type in 2015 & 2019

Figure 36. China Chronic Kidney Disease Drugs Revenue Share by Application (2015-2020)

Figure 37. China Chronic Kidney Disease Drugs Revenue Growth Rate by Application in 2015 & 2019

Figure 38. North America Chronic Kidney Disease Drugs Sales Growth Rate 2015-2020 (K MT)

Figure 39. North America Chronic Kidney Disease Drugs Revenue Growth Rate 2015-2020 (US$ Million)

Figure 40. North America Chronic Kidney Disease Drugs Sales Market Share by Country in 2019

Figure 41. North America Chronic Kidney Disease Drugs Revenue Market Share by Country in 2019

Figure 42. U.S. Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)

Figure 43. U.S. Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 44. Canada Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)

Figure 45. Canada Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 46. Europe Chronic Kidney Disease Drugs Sales Growth Rate 2015-2020 (K MT)

Figure 47. Europe Chronic Kidney Disease Drugs Revenue Growth Rate 2015-2020 (US$ Million)

Figure 48. Europe Chronic Kidney Disease Drugs Sales Market Share by Country in 2019

Figure 49. Europe Chronic Kidney Disease Drugs Revenue Market Share by Country in 2019

Figure 50. Germany Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)

Figure 51. Germany Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 52. France Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)

Figure 53. France Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 54. U.K. Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)

Figure 55. U.K. Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 56. Italy Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)

Figure 57. Italy Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 58. Russia Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)

Figure 59. Russia Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 60. Asia Pacific Chronic Kidney Disease Drugs Sales Growth Rate 2015-2020 (K MT)

Figure 61. Asia Pacific Chronic Kidney Disease Drugs Revenue Growth Rate 2015-2020 (US$ Million)

Figure 62. Asia Pacific Chronic Kidney Disease Drugs Sales Market Share by Region in 2019

Figure 63. Asia Pacific Chronic Kidney Disease Drugs Revenue Market Share by Region in 2019

Figure 64. China Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)

Figure 65. China Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 66. Japan Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)

Figure 67. Japan Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 68. South Korea Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)

Figure 69. South Korea Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 70. India Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)

Figure 71. India Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 72. Australia Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)

Figure 73. Australia Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 74. Taiwan Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)

Figure 75. Taiwan Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 76. Indonesia Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)

Figure 77. Indonesia Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 78. Thailand Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)

Figure 79. Thailand Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 80. Malaysia Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)

Figure 81. Malaysia Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 82. Philippines Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)

Figure 83. Philippines Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 84. Vietnam Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)

Figure 85. Vietnam Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 86. Latin America Chronic Kidney Disease Drugs Sales Growth Rate 2015-2020 (K MT)

Figure 87. Latin America Chronic Kidney Disease Drugs Revenue Growth Rate 2015-2020 (US$ Million)

Figure 88. Latin America Chronic Kidney Disease Drugs Sales Market Share by Country in 2019

Figure 89. Latin America Chronic Kidney Disease Drugs Revenue Market Share by Country in 2019

Figure 90. Mexico Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)

Figure 91. Mexico Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 92. Brazil Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)

Figure 93. Brazil Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 94. Argentina Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)

Figure 95. Argentina Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 96. Middle East and Africa Chronic Kidney Disease Drugs Sales Growth Rate 2015-2020 (K MT)

Figure 97. Middle East and Africa Chronic Kidney Disease Drugs Revenue Growth Rate 2015-2020 (US$ Million)

Figure 98. Middle East and Africa Chronic Kidney Disease Drugs Sales Market Share by Country in 2019

Figure 99. Middle East and Africa Chronic Kidney Disease Drugs Revenue Market Share by Country in 2019

Figure 100. Turkey Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)

Figure 101. Turkey Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 102. Saudi Arabia Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)

Figure 103. Saudi Arabia Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 104. U.A.E Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)

Figure 105. U.A.E Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 106. Porter's Five Forces Analysis

Figure 107. Chronic Kidney Disease Drugs Value Chain

Figure 108. Channels of Distribution

Figure 109. Distributors Profiles

Figure 110. Bottom-up and Top-down Approaches for This Report

Figure 111. Data Triangulation

Figure 112. Key Executives Interviewed

Keryx Biopharmaceuticals, Inc

Kissei Pharmaceutical Co., Ltd

AbbVie

GlaxoSmithKline

Sanofi

F. Hoffmann-La Roche Ltd

Pfizer

AstraZeneca

Amgen

Teva Pharmaceutical Industries

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3120

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase